Can we predict the prognosis of COPD with a routine blood test?
Authors Xiong W, Xu M, Zhao YF, Wu XL, Pudasaini B, Liu JM
Received 6 October 2016
Accepted for publication 9 November 2016
Published 13 February 2017 Volume 2017:12 Pages 615—625
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Professor Hsiao-Chi Chuang
Peer reviewer comments 3
Editor who approved publication: Dr Richard Russell
Wei Xiong,1 Mei Xu,2 Yunfeng Zhao,3 Xueling Wu,4 Bigyan Pudasaini,1 Jin-ming Liu1
1Department of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 2Department of Pediatrics, Gongli Hospital, Second Military Medical University, 3Department of Respiratory Medicine, Punan Hospital, 4Department of Respiratory Medicine, Renji Hospital, Jiaotong University School of Medicine, Shanghai, People’s Republic of China
Background: The major characteristic of COPD is systemic inflammation. The parameters such as neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-basophil ratio (EBR) in routine blood test (RBT) are considered to be the underlying biomarkers of inflammation. We hypothesized that the prognosis of patients with COPD can be predicted with RBT.
Methods: Patients with COPD in stable stage were enrolled. The RBT, pulmonary function testing (PFT), BODE index, C-reactive protein (CRP), procalcitonin, and erythrocyte sedimentation rate (ESR) were performed at enrollment and every follow-up once in every 3 months during the 24-month follow-up period. Meanwhile, exacerbation count and mortality incidence were recorded. The correlation between the prognostic biomarkers and the prognosis of patients was analyzed.
Results: The NLR and EBR in RBT have a significant correlation with the severity of patients with COPD. The NLR is an independent predictor for mortality and the EBR is an independent predictor for exacerbation.
Conclusion: As an inexpensive, accessible, and convenient assay, RBT may be used as a practical means in the prediction of prognosis of patients with COPD in future clinical settings.
Keywords: COPD, prognosis, inflammation, routine blood test, neutrophil-to-lymphocyte ratio, eosinophil-to-basophil ratio
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]